Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 3865Neoplasms 2991Prostatic Neoplasms 1754Colorectal Neoplasms 1431Lung Neoplasms 1332Motor Activity 805Head and Neck Neoplasms 686Pancreatic Neoplasms 664Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Hepatocellular 632Carcinoma, Non-Small-Cell Lung 631Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 486Ovarian Neoplasms 441Anxiety Disorders 420Pain 419Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 376Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 351Fatigue 340Multiple Myeloma 323Melanoma 323Lymphoma 306Depression 306Endometrial Neoplasms 290Liver Neoplasms 280

Interventions

Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Humoral Hypercalcemia Of Malignancy × Clear all
NCT00458796 2022-05-27

Comparison of Two Schedules of Zoledronic Acid in Treating Patients With Breast Cancer That Has Spread to the Bone

University of Leeds

Phase NA Terminated
1,500 enrolled
Breast

Humoral Hypercalcemia Of Malignancy, Breast Neoplasms, Neoplasm Metastasis, Pain, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡